These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36457758)

  • 1. Low skull bone density is associated with poor motor prognosis in women with Parkinson's disease.
    Jeong SH; Hong N; Lee HS; Han S; Lee YG; Lee Y; Rhee Y; Sohn YH; Lee PH
    Front Aging Neurosci; 2022; 14():1053786. PubMed ID: 36457758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does dopamine deficiency affect sex-dependent prognosis in Parkinson's disease?
    Jeong SH; Lee HS; Lee PH; Sohn YH; Chung SJ
    Parkinsonism Relat Disord; 2022 Sep; 102():57-63. PubMed ID: 35961198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson's disease.
    Yoo HS; Chung SJ; Chung SJ; Moon H; Oh JS; Kim JS; Hong JY; Ye BS; Sohn YH; Lee PH
    Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):423-431. PubMed ID: 29075830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter hyperintensities and risk of levodopa-induced dyskinesia in Parkinson's disease.
    Chung SJ; Yoo HS; Lee YH; Jung JH; Baik K; Ye BS; Sohn YH; Lee PH
    Ann Clin Transl Neurol; 2020 Feb; 7(2):229-238. PubMed ID: 32032471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychiatric Burden Is a Predictor of Early Freezing and Motor Progression in Drug-Naïve Parkinson's Disease.
    Jeong SH; Yoo HS; Chung SJ; Jung JH; Lee YH; Baik K; Sohn YH; Lee PH
    J Parkinsons Dis; 2021; 11(4):1947-1956. PubMed ID: 34151858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of statins on dopamine loss and prognosis in Parkinson's disease.
    Jeong SH; Lee HS; Chung SJ; Yoo HS; Jung JH; Baik K; Lee YH; Sohn YH; Lee PH
    Brain; 2021 Nov; 144(10):3191-3200. PubMed ID: 34347020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. White Matter Hyperintensities, Dopamine Loss, and Motor Deficits in De Novo Parkinson's Disease.
    Jeong SH; Lee HS; Jung JH; Baik K; Lee YH; Yoo HS; Sohn YH; Chung SJ; Lee PH
    Mov Disord; 2021 Jun; 36(6):1411-1419. PubMed ID: 33513293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of dipeptidyl peptidase-4 inhibitors in diabetic Parkinson's disease.
    Jeong SH; Chung SJ; Yoo HS; Hong N; Jung JH; Baik K; Lee YH; Sohn YH; Lee PH
    Brain; 2021 May; 144(4):1127-1137. PubMed ID: 33895825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premorbid Educational Attainment and Long-Term Motor Prognosis in Parkinson's Disease.
    Jeong SH; Chung SJ; Yoo HS; Jung JH; Baik K; Lee YH; Lee PH; Sohn YH
    J Parkinsons Dis; 2022; 12(1):129-136. PubMed ID: 34542032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perivascular Spaces in the Basal Ganglia and Long-term Motor Prognosis in Newly Diagnosed Parkinson Disease.
    Chung SJ; Yoo HS; Shin NY; Park YW; Lee HS; Hong JM; Kim YJ; Lee SK; Lee PH; Sohn YH
    Neurology; 2021 Apr; 96(16):e2121-e2131. PubMed ID: 33653906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease.
    Hong JY; Oh JS; Lee I; Sunwoo MK; Ham JH; Lee JE; Sohn YH; Kim JS; Lee PH
    Neurology; 2014 May; 82(18):1597-604. PubMed ID: 24719485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White matter hyperintensities as a predictor of freezing of gait in Parkinson's disease.
    Chung SJ; Lee YH; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2019 Sep; 66():105-109. PubMed ID: 31324555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial I-123-FP-CIT SPECT Image Findings of Parkinson's Disease Patients With Levodopa-Induced Dyskinesia.
    Jeong EH; Sunwoo MK; Song YS
    Front Neurol; 2018; 9():1133. PubMed ID: 30619078
    [No Abstract]   [Full Text] [Related]  

  • 14. Associations between white matter hyperintensities, striatal dopamine loss, and cognition in drug-naïve Parkinson's disease.
    Jeong SH; Lee HS; Jung JH; Baik K; Sohn YH; Chung SJ; Lee PH
    Parkinsonism Relat Disord; 2022 Apr; 97():1-7. PubMed ID: 35276583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effect of estrogen on nigrostriatal dopaminergic neurons in drug-naïve postmenopausal Parkinson's disease.
    Lee YH; Cha J; Chung SJ; Yoo HS; Sohn YH; Ye BS; Lee PH
    Sci Rep; 2019 Jul; 9(1):10531. PubMed ID: 31324895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.
    Chung SJ; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2018 Jun; 51():43-48. PubMed ID: 29526657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relations of clinical symptoms with dopamine transporter imaging in drug-naïve Parkinson's disease.
    Mito Y; Yabe I; Yaguchi H; Sato C; Takei T; Terae S; Tajima Y
    Clin Neurol Neurosurg; 2020 Sep; 196():105960. PubMed ID: 32593043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Pattern of Striatal Dopamine Depletion as a Prognostic Marker in De Novo Parkinson Disease.
    Chung SJ; Yoo HS; Lee HS; Oh JS; Kim JS; Sohn YH; Lee PH
    Clin Nucl Med; 2018 Nov; 43(11):787-792. PubMed ID: 30153150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Putaminal dopamine depletion in de novo Parkinson's disease predicts future development of wearing-off.
    Chung SJ; Lee Y; Oh JS; Kim JS; Lee PH; Sohn YH
    Parkinsonism Relat Disord; 2018 Aug; 53():96-100. PubMed ID: 29776864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease.
    Fiorenzato E; Antonini A; Bisiacchi P; Weis L; Biundo R
    Mov Disord; 2021 Oct; 36(10):2303-2313. PubMed ID: 34124799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.